Literature DB >> 33407098

MATHLA: a robust framework for HLA-peptide binding prediction integrating bidirectional LSTM and multiple head attention mechanism.

Yilin Ye1,2, Jian Wang1, Yunwan Xu1, Yi Wang1, Youdong Pan1, Qi Song1, Xing Liu3, Ji Wan4.   

Abstract

BACKGROUND: Accurate prediction of binding between class I human leukocyte antigen (HLA) and neoepitope is critical for target identification within personalized T-cell based immunotherapy. Many recent prediction tools developed upon the deep learning algorithms and mass spectrometry data have indeed showed improvement on the average predicting power for class I HLA-peptide interaction. However, their prediction performances show great variability over individual HLA alleles and peptides with different lengths, which is particularly the case for HLA-C alleles due to the limited amount of experimental data. To meet the increasing demand for attaining the most accurate HLA-peptide binding prediction for individual patient in the real-world clinical studies, more advanced deep learning framework with higher prediction accuracy for HLA-C alleles and longer peptides is highly desirable.
RESULTS: We present a pan-allele HLA-peptide binding prediction framework-MATHLA which integrates bi-directional long short-term memory network and multiple head attention mechanism. This model achieves better prediction accuracy in both fivefold cross-validation test and independent test dataset. In addition, this model is superior over existing tools regarding to the prediction accuracy for longer ligand ranging from 11 to 15 amino acids. Moreover, our model also shows a significant improvement for HLA-C-peptide-binding prediction. By investigating multiple-head attention weight scores, we depicted possible interaction patterns between three HLA I supergroups and their cognate peptides.
CONCLUSION: Our method demonstrates the necessity of further development of deep learning algorithm in improving and interpreting HLA-peptide binding prediction in parallel to increasing the amount of high-quality HLA ligandome data.

Entities:  

Keywords:  Cancer immunotherapy; Deep learning; HLA-peptide binding prediction

Year:  2021        PMID: 33407098     DOI: 10.1186/s12859-020-03946-z

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


  19 in total

1.  Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC-Peptide Binding Data Set.

Authors:  Maria Bonsack; Stephanie Hoppe; Jan Winter; Diana Tichy; Christine Zeller; Marius D Küpper; Eva C Schitter; Renata Blatnik; Angelika B Riemer
Journal:  Cancer Immunol Res       Date:  2019-03-22       Impact factor: 11.151

2.  The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands.

Authors:  David Gfeller; Philippe Guillaume; Justine Michaux; Hui-Song Pak; Roy T Daniel; Julien Racle; George Coukos; Michal Bassani-Sternberg
Journal:  J Immunol       Date:  2018-11-14       Impact factor: 5.422

3.  MHCflurry: Open-Source Class I MHC Binding Affinity Prediction.

Authors:  Timothy J O'Donnell; Alex Rubinsteyn; Maria Bonsack; Angelika B Riemer; Uri Laserson; Jeff Hammerbacher
Journal:  Cell Syst       Date:  2018-06-27       Impact factor: 10.304

4.  [The surgeon's tactics in craniocerebral trauma combined with injury to the extremities].

Authors:  A P Fraerman; N A Zvonkov
Journal:  Ortop Travmatol Protez       Date:  1971-01

5.  NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data.

Authors:  Vanessa Jurtz; Sinu Paul; Massimo Andreatta; Paolo Marcatili; Bjoern Peters; Morten Nielsen
Journal:  J Immunol       Date:  2017-10-04       Impact factor: 5.422

6.  Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.

Authors:  Ugur Sahin; Evelyna Derhovanessian; Matthias Miller; Björn-Philipp Kloke; Petra Simon; Martin Löwer; Valesca Bukur; Arbel D Tadmor; Ulrich Luxemburger; Barbara Schrörs; Tana Omokoko; Mathias Vormehr; Christian Albrecht; Anna Paruzynski; Andreas N Kuhn; Janina Buck; Sandra Heesch; Katharina H Schreeb; Felicitas Müller; Inga Ortseifer; Isabel Vogler; Eva Godehardt; Sebastian Attig; Richard Rae; Andrea Breitkreuz; Claudia Tolliver; Martin Suchan; Goran Martic; Alexander Hohberger; Patrick Sorn; Jan Diekmann; Janko Ciesla; Olga Waksmann; Alexandra-Kemmer Brück; Meike Witt; Martina Zillgen; Andree Rothermel; Barbara Kasemann; David Langer; Stefanie Bolte; Mustafa Diken; Sebastian Kreiter; Romina Nemecek; Christoffer Gebhardt; Stephan Grabbe; Christoph Höller; Jochen Utikal; Christoph Huber; Carmen Loquai; Özlem Türeci
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

7.  NetMHCpan, a method for MHC class I binding prediction beyond humans.

Authors:  Ilka Hoof; Bjoern Peters; John Sidney; Lasse Eggers Pedersen; Alessandro Sette; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2008-11-12       Impact factor: 2.846

8.  Predicting HLA class II antigen presentation through integrated deep learning.

Authors:  Binbin Chen; Michael S Khodadoust; Niclas Olsson; Lisa E Wagar; Ethan Fast; Chih Long Liu; Yagmur Muftuoglu; Brian J Sworder; Maximilian Diehn; Ronald Levy; Mark M Davis; Joshua E Elias; Russ B Altman; Ash A Alizadeh
Journal:  Nat Biotechnol       Date:  2019-10-14       Impact factor: 54.908

9.  HLA class I binding prediction via convolutional neural networks.

Authors:  Yeeleng S Vang; Xiaohui Xie
Journal:  Bioinformatics       Date:  2017-09-01       Impact factor: 6.937

10.  A large peptidome dataset improves HLA class I epitope prediction across most of the human population.

Authors:  Siranush Sarkizova; Susan Klaeger; Phuong M Le; Letitia W Li; Giacomo Oliveira; Hasmik Keshishian; Christina R Hartigan; Wandi Zhang; David A Braun; Keith L Ligon; Pavan Bachireddy; Ioannis K Zervantonakis; Jennifer M Rosenbluth; Tamara Ouspenskaia; Travis Law; Sune Justesen; Jonathan Stevens; William J Lane; Thomas Eisenhaure; Guang Lan Zhang; Karl R Clauser; Nir Hacohen; Steven A Carr; Catherine J Wu; Derin B Keskin
Journal:  Nat Biotechnol       Date:  2019-12-16       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.